NAMA Shortcuts
Member Directory
Best of NAMA 2014
Upcoming Events
Chapters
Agri-Marketing Conf
More NAMA












ZOETIS HOLDS ITS FIRST SHAREHOLDER MEETING
Source: Zoetis news release

Zoetis Inc. (NYSE:ZTS) marked another milestone in the company's launch as an independent public company today, conducting its first-ever Annual Meeting of Shareholders.

The company, which became fully independent in June 2013 after completing its separation from Pfizer, hosted the event this morning at the Hilton Short Hills Hotel, in Short Hills, New Jersey.

Zoetis Chairman Michael McCallister presided over the business portion of the meeting and shareholder voting. He was joined by Zoetis Chief Executive Officer Juan Ramón Alaix who discussed the company's first year as an independent company, the core strengths of its business model, and its long-term value proposition for shareholders.

A full replay of the meeting is available at http://investor.zoetis.com/events-presentations, along with a copy of Mr. Alaix's prepared remarks and presentation.

Preliminary results from the Annual Meeting of Shareholders indicate the following results of shareholder voting:

• Gregory Norden, Louise M. Parent and Robert W. Scully have been elected as directors for three-year terms.

• Shareholders ratified and approved the selection of KPMG LLP as the company's independent registered public accounting firm for the 2014 fiscal year.

• Shareholders voted to approve, on an advisory basis, the compensation of the company's named executive officers, and to approve the holding of an advisory vote on executive compensation every year. In addition, shareholders voted to approve the company's 2013 Equity and Incentive Plan.

The final results of the shareholder voting are subject to verification by the independent election inspectors and will be filed in a Form 8-K and available on the company's website.

About Zoetis

Zoetis (zô-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. In 2013, the company generated annual revenue of $4.6 billion. With approximately 9,800 employees worldwide at the beginning of 2014, Zoetis has a local presence in approximately 70 countries, including 28 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information, visit www.zoetis.com.


Search News & Articles




















Proudly associated with:
American Business Media Canadian Agri-Marketing Association National Agri-Marketing Association
Agricultural Relations Council National Association of Farm Broadcasters American Agricultural Editors' Association Livestock Publications Council
All content © Copyright 2014, Henderson Communications LLC. | User Agreement